Cargando…

Emerging roles of Nrf2 signal in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) causes considerable mortality in the world. Owing to molecular biological progress, treatments in adenocarcinoma have evolved revolutionarily while those in squamous lung cancer remain unsatisfied. Recent studies revealed high-frequency alteration of Kelch-like ECH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Yijun, Liu, Qian, He, Xuelian, Yuan, Xun, Chen, Yuan, Chu, Qian, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769825/ https://www.ncbi.nlm.nih.gov/pubmed/26922479 http://dx.doi.org/10.1186/s13045-016-0246-5

Ejemplares similares

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer
por: Tian, Yijun, et al.
Publicado: (2016)

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application
por: Yuan, Xun, et al.
Publicado: (2014)

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
por: Sun, Wei, et al.
Publicado: (2015)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers
por: Tian, Yijun, et al.
Publicado: (2017)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

Prognostic significance of KRT19 in Lung Squamous Cancer
por: Yuan, Xun, et al.
Publicado: (2021)

The expression profile and clinic significance of the SIX family in non-small cell lung cancer
por: Liu, Qian, et al.
Publicado: (2016)

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling
por: Han, Na, et al.
Publicado: (2015)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

The clinical significance of CXCL5 in non-small cell lung cancer
por: Wu, Kongju, et al.
Publicado: (2017)

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
por: Xu, Hanxiao, et al.
Publicado: (2016)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
por: Yuan, Xun, et al.
Publicado: (2016)

The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer
por: Fan, Qiang, et al.
Publicado: (2020)

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis
por: Yuan, Xun, et al.
Publicado: (2015)

EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
por: Bai, Xianguang, et al.
Publicado: (2019)

The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
por: Yan, Tinghao, et al.
Publicado: (2022)

NRF2 regulates serine biosynthesis in non-small cell lung cancer
por: DeNicola, Gina M., et al.
Publicado: (2015)

The emerging role of the Nrf2–Keap1 signaling pathway in cancer
por: Jaramillo, Melba C., et al.
Publicado: (2013)

Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
por: Hallis, Steffanus P., et al.
Publicado: (2023)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

Emerging role of SIRT2 in non-small cell lung cancer
por: Zheng, Mengge, et al.
Publicado: (2021)

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer
por: Lv, Meiwen, et al.
Publicado: (2022)

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
por: Chu, Qian, et al.
Publicado: (2014)

The emerging role of Nrf2 in dermatotoxicology
por: Tan, Nguan S, et al.
Publicado: (2014)

Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
por: Zhao, Jiangang, et al.
Publicado: (2020)

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
por: Yuan, Min, et al.
Publicado: (2019)

Endogenous Dach1 in cancer
por: Wu, Kongming, et al.
Publicado: (2015)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
por: Yi, Ming, et al.
Publicado: (2021)

Notch signaling pathway: architecture, disease, and therapeutics
por: Zhou, Binghan, et al.
Publicado: (2022)

Chimeric antigen receptor T cells: a novel therapy for solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017)

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
por: Bai, Xianguang, et al.
Publicado: (2018)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Saponins from Panax japonicus ameliorate age-related renal fibrosis by inhibition of inflammation mediated by NF-κB and TGF-β1/Smad signaling and suppression of oxidative stress via activation of Nrf2-ARE signaling
por: Gao, Yan, et al.
Publicado: (2021)

Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
por: Singh, Anju, et al.
Publicado: (2006)

NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
por: Kinslow, Connor J., et al.
Publicado: (2022)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
por: Boland, William, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_74ogb8tnnffjilknoqi6hcjt72